These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 34797727)

  • 1. Consumer Experiences with Delta-8-THC: Medical Use, Pharmaceutical Substitution, and Comparisons with Delta-9-THC.
    Kruger DJ; Kruger JS
    Cannabis Cannabinoid Res; 2023 Feb; 8(1):166-173. PubMed ID: 34797727
    [No Abstract]   [Full Text] [Related]  

  • 2. Delta-8-THC: Delta-9-THC's nicer younger sibling?
    Kruger JS; Kruger DJ
    J Cannabis Res; 2022 Jan; 4(1):4. PubMed ID: 34980292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study.
    Trevitt BT; Bailey S; Mills L; Arkell TR; Suraev A; McGregor IS; Lintzeris N
    PLoS One; 2024; 19(2):e0297092. PubMed ID: 38354169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Dark Side of Cannabidiol: The Unanticipated Social and Clinical Implications of Synthetic Δ
    Geci M; Scialdone M; Tishler J
    Cannabis Cannabinoid Res; 2023 Apr; 8(2):270-282. PubMed ID: 36264171
    [No Abstract]   [Full Text] [Related]  

  • 5. Public interest in ∆
    Leas EC; Nobles AL; Shi Y; Hendrickson E
    Int J Drug Policy; 2022 Mar; 101():103557. PubMed ID: 34952279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical Cannabis Use and Inflammatory Cytokines and Chemokines Among Adult Chronic Pain Patients.
    Ajrawat P; Yang Y; Wasilewski E; Leroux T; Ladha KS; Bhatia A; Singh M; Thaker S; Kapoor M; Furlan AD; Kotra LP; Clarke H
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):267-281. PubMed ID: 36342776
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemistry and Pharmacology of Delta-8-Tetrahydrocannabinol.
    Abdel-Kader MS; Radwan MM; Metwaly AM; Eissa IH; Hazekamp A; ElSohly MA
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38542886
    [No Abstract]   [Full Text] [Related]  

  • 8. Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores.
    Spindle TR; Sholler DJ; Cone EJ; Murphy TP; ElSohly M; Winecker RE; Flegel RR; Bonn-Miller MO; Vandrey R
    JAMA Netw Open; 2022 Jul; 5(7):e2223019. PubMed ID: 35857320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding Cannabis-Based Therapeutics in Sports Medicine.
    Maurer GE; Mathews NM; Schleich KT; Slayman TG; Marcussen BL
    Sports Health; 2020; 12(6):540-546. PubMed ID: 32936058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure.
    Lambros AM; Sagar KA; Dahlgren MK; Kosereisoglu D; El-Abboud C; Smith RT; Gruber SA
    Sci Rep; 2023 Apr; 13(1):5869. PubMed ID: 37041309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Transformer-Based Topic Modeling to Examine Discussions of Delta-8 Tetrahydrocannabinol: Content Analysis.
    Smith BP; Hoots B; DePadilla L; Roehler DR; Holland KM; Bowen DA; Sumner SA
    J Med Internet Res; 2023 Dec; 25():e49469. PubMed ID: 38127427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta-8 THC use in US adults: Sociodemographic characteristics and correlates.
    Livne O; Budney A; Borodovsky J; Walsh C; Shmulewitz D; Fink DS; Struble CA; Habib M; Aharonovich E; Hasin DS
    Addict Behav; 2022 Oct; 133():107374. PubMed ID: 35644057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20).
    Lintzeris N; Mills L; Abelev SV; Suraev A; Arnold JC; McGregor IS
    Harm Reduct J; 2022 Jul; 19(1):88. PubMed ID: 35907959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment.
    Bidwell LC; Karoly HC; Torres MO; Master A; Bryan AD; Hutchison KE
    Psychopharmacology (Berl); 2022 Feb; 239(2):385-397. PubMed ID: 34708254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty21.
    Sakal C; Lynskey M; Schlag AK; Nutt DJ
    Psychopharmacology (Berl); 2022 May; 239(5):1147-1155. PubMed ID: 33970291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping cannabis potency in medical and recreational programs in the United States.
    Cash MC; Cunnane K; Fan C; Romero-Sandoval EA
    PLoS One; 2020; 15(3):e0230167. PubMed ID: 32214334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported THC content and associations with perceptions of feeling high among cannabis consumers.
    Lineham J; Wadsworth E; Hammond D
    Drug Alcohol Rev; 2023 Jul; 42(5):1142-1152. PubMed ID: 37062952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating THC Consumption from Smoked and Vaped Cannabis Products in an Online Survey of Adults Who Use Cannabis.
    Budney AJ; Borodovsky JT; Struble CA; Habib MI; Shmulewitz D; Livne O; Aharonovich E; Walsh C; Cuttler C; Hasin DS
    Cannabis Cannabinoid Res; 2024 Apr; 9(2):688-698. PubMed ID: 36521175
    [No Abstract]   [Full Text] [Related]  

  • 19. Patterns of Medical Cannabis Use Among Older Adults from a Cannabis Dispensary in New York State.
    Kaufmann CN; Kim A; Miyoshi M; Han BH
    Cannabis Cannabinoid Res; 2022 Apr; 7(2):224-230. PubMed ID: 33998868
    [No Abstract]   [Full Text] [Related]  

  • 20. Dark Classics in Chemical Neuroscience: Δ
    Banister SD; Arnold JC; Connor M; Glass M; McGregor IS
    ACS Chem Neurosci; 2019 May; 10(5):2160-2175. PubMed ID: 30689342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.